Lincoln National Corp Sanofi Transaction History

Lincoln National Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	BUY	$45.75 - $52.48 $162,412 - $186,304	3,550 Added 63.83%	9,112 $442,000
Q4 2023 Feb 06, 2024	SELL	$43.13 - $54.79 $11,170 - $14,190	-259 Reduced 4.45%	5,562 $276,000
Q3 2023 Nov 03, 2023	SELL	$50.95 - $55.2 $101 - $110	-2 Reduced 0.03%	5,821 $312,000
Q2 2023 Aug 04, 2023	SELL	$50.45 - $57.18 $2,320 - $2,630	-46 Reduced 0.78%	5,823 $313,000
Q1 2023 May 01, 2023	BUY	$45.86 - $54.45 $5,594 - $6,642	122 Added 2.12%	5,869 $319,000
Q4 2022 Feb 07, 2023	BUY	$38.86 - $48.55 $13,134 - $16,409	338 Added 6.25%	5,747 $278,000
Q3 2022 Nov 03, 2022	BUY	$37.22 - $100.5 $7,444 - $20,100	200 Added 3.84%	5,409 $206,000
Q2 2022 Aug 02, 2022	BUY	$48.99 - $57.46 $48,451 - $56,827	989 Added 23.44%	5,209 $261,000
Q1 2022 May 09, 2022	BUY	$48.48 - $53.65 $204,585 - $226,403	4,220 New	4,220 $217,000

810

262M

1.82M

1.64M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $139B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Lincoln National Corp, based on Form 13F filings with the SEC.

Stay updated on Lincoln National Corp with notifications on news.